These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 314597)

  • 21. Dopaminergic activity of quipazine.
    Schechter MD; Concannon JT
    Pharmacol Biochem Behav; 1982 Sep; 17(3):393-7. PubMed ID: 7146043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.
    Darmani NA; Johnson JC
    Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Yohimbine: behavioral and biochemical effects in mice.
    Sanghvi I; Gershon S
    Arch Int Pharmacodyn Ther; 1974 Jul; 210(1):108-20. PubMed ID: 4280277
    [No Abstract]   [Full Text] [Related]  

  • 25. Behavioral effects of quipazine in the cat.
    Trulson ME; Brandstetter JW; Crisp T; Jacobs BL
    Eur J Pharmacol; 1982 Mar; 78(3):295-305. PubMed ID: 6461558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low responsiveness to agents evoking 5-HT2 receptor-mediated behaviors in Sardinian alcohol-preferring rats.
    Ciccocioppo R; Panocka I; Stefanini E; Gessa GL; Massi M
    Pharmacol Biochem Behav; 1995 May; 51(1):21-7. PubMed ID: 7542392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serotonin agonist actions of p-chlorophenylalanine.
    Sloviter RS; Drust EG; Connor JD
    Neuropharmacology; 1978 Dec; 17(12):1029-33. PubMed ID: 154622
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of intracerebroventricularly administered octopamine, phenylethylamine and epinephrine on the central serotonergic system of the rat.
    Jagiełło-Wójtowicz E
    Pol J Pharmacol Pharm; 1982; 34(4):193-200. PubMed ID: 6820690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of central serotonin manipulation on hyperactive and stereotyped behaviour.
    Carter CJ; Pycock CJ
    Life Sci; 1978 Sep; 23(9):953-60. PubMed ID: 568208
    [No Abstract]   [Full Text] [Related]  

  • 30. A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists.
    Green AR; Hall JE; Rees AR
    Br J Pharmacol; 1981 Jul; 73(3):703-19. PubMed ID: 6166345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discriminative-stimulus effects of quipazine and l-5-hydroxytryptophan in relation to serotonin binding sites in the pigeon.
    Walker EA; Yamamoto T; Hollingsworth PJ; Smith CB; Woods JH
    J Pharmacol Exp Ther; 1991 Nov; 259(2):772-82. PubMed ID: 1941625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the behavioral effects of para-chloroamphetamine, chlordimeform, quipazine, and intraventricular serotonin in the rat.
    Pfister WR; Noland V; Lowy MT; Nichols DE; Yim GK
    Commun Psychopharmacol; 1978; 2(4):287-95. PubMed ID: 729354
    [No Abstract]   [Full Text] [Related]  

  • 33. Lack of supersensitivity to L-5-hydroxytryptophan following chronic methysergide treatment.
    Trulson ME; Stark AD; Jacobs BL
    J Pharm Pharmacol; 1977 Jun; 29(6):382-4. PubMed ID: 18584
    [No Abstract]   [Full Text] [Related]  

  • 34. 5-Hydroxytryptamine-like properties of m-chlorophenylpiperazine: comparison with quipazine.
    Rokosz-Pelc A; Antkiewicz-Michaluk L; Vetulani J
    J Pharm Pharmacol; 1980 Mar; 32(3):220-2. PubMed ID: 6103943
    [No Abstract]   [Full Text] [Related]  

  • 35. Self-selection of 5-hydroxytryptophan in dl-para-chlorophenylalanine treated rats.
    Nance DM; Kilbey MM
    Physiol Behav; 1972 Mar; 8(3):545-7. PubMed ID: 4260975
    [No Abstract]   [Full Text] [Related]  

  • 36. An examination of the 'wet dog' shake behaviour in rats produced by acute administration of sodium n-dipropylacetate.
    Fletcher A; Harding V
    J Pharm Pharmacol; 1981 Dec; 33(12):811-3. PubMed ID: 6121863
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of quipazine and methysergide on play in juvenile rats.
    Normansell L; Panksepp J
    Pharmacol Biochem Behav; 1985 May; 22(5):885-7. PubMed ID: 2989950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The acute effects of 5HTP, fluoxetine and quipazine on insulin and glucagon release in the intact rat.
    Jacoby JH; Bryce GF
    Horm Metab Res; 1979 Feb; 11(2):90-4. PubMed ID: 312241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Further evidence for an anomalous regulation of cortical 5-HT2 receptors: studies with 5-HT precursors.
    Koshikawa N; Koshikawa F; Stephenson JD
    Eur J Pharmacol; 1990 Mar; 178(3):365-9. PubMed ID: 2340865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of pharmacological manipulation of serotonergic and dopaminergic mechanisms on plasma prolactin in ovariectomized, estrogen-treated rats.
    Lawson DM; Gala RR
    Endocrinology; 1978 Mar; 102(3):973-81. PubMed ID: 311279
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.